Skip to main content
Figure 5 | BMC Gastroenterology

Figure 5

From: Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)

Figure 5

Proportion of patients with improvements in upper gastrointestinal symptoms after 2 weeks and 4 weeks of treatment with omeprazole, famotidine, mosapride or teprenone. Symptoms were scored using the Global Overall Severity (GOS) scale, and symptom improvement was defined as a decrease in GOS by ≥ 2 grades. *p < 0.05, **p < 0.01 vs omeprazole.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us